The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey […]
Update
DrugPatentWatch Headlines Swissbiotech Annual Report
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
Finding and Evaluating Branded and Generic Market Entry Opportunities
Here’s a copy of the recent talk on Finding and Evaluating Branded and Generic Market Entry Opportunities. It’s based on
Finding and Evaluating Branded and Generic Market Entry Opportunities Read Post »
DrugPatentWatch Alternatives
Considering switching to DrugPatentWatch? See why others have come to us. DrugPatentWatch Alternatives
See What Others are Saying About DrugPatentWatch
We thought you might be interested in some of the great reviews we’re getting over at software review site G2Crowd.
See What Others are Saying About DrugPatentWatch Read Post »
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions Read Post »
Try our one-month starter plans
Do you want an easier way to access DrugPatentWatch without a long-term commitment? We have monthly starter plans designed for short-term
